TechNet-21 - Forum

  1. Moderator
  2. Announcements
  3. Thursday, 14 March 2002
POST 00435E :GAVI Update (resend) 14 March 2002 _________________________________________________ The last GAVI Update Posting (POST00434E) was truncated for obscure reasons. So here it is again complete. __________________________________________________ GENERAL NOTE ON THE VACCINE FUND APPLICATION PROCESS Countries which have not applied for the Injection Safety sub-account are strongly urged to apply by the next round (1 May 2002). GAVI BOARD 01/03/02 from GAVI Secretariat: The 7th Board Meeting will be held from 10-11 March 2002 in Stockholm, Sweden. 01/03/02 from GAVI Secretariat: In recognition of the fact that additional resources are required to support the introduction of new vaccines (such as advocacy, upgrading of infrastructure, etc), the GAVI Board during its 8 January 2002 session approved the allocation of a fixed amount of US $100,000 to all countries who have received approval of support for the introduction of new and under-used vaccines. The aim of this additional support from the Fund is to bridge the resource gap at the time of vaccine introduction and allow critical activities in the national vaccine introduction plan to be conducted in a timely manner. The government and ICC partners are expected to make additional resources available to ensure the safe and effective introduction of vaccines nation-wide. REVIEW PROCESS 01/03/02 from GAVI Secretariat: For the 6th round, nine countries have submitted new applications (one for Immunization Services Strengthening, three for New Vaccines and nine for Injection Safety) one has resubmitted application for Injection Safety, and three have provided the requested conditions from previous applications. COUNTRY COORDINATION & TECHNICAL SUPPORT 01/03/02 from the Task Force on Country Coordination: The Core TFCC meeting will be held from 23-24 April 2002 in Geneva, Switzerland. The preliminary agenda is being developed and will be available shortly. FINANCING TASK FORCE 04/04/02 from Violaine Mitchell, GAVI Financing Task Force: The draft guidelines for the preparation of financial sustainability plan guidelines and the draft financial sustainability assessment tool are being pre-tested in Ghana and Cambodia. There will be a debriefing meeting March 12-14 in London. Reports from these pre-tests will be available the web or from [email protected] The financial sustainability guidelines will be revised and submitted to the GAVI Board for approval in April 2002, and then circulated to all first round Vaccine Fund countries. Countries and their development partners are required to submit financial sustainability plans in year two of receiving catalytic support from the Vaccine Fund outlining how the improved and expanded immunization programs will be sustained into the future. 01/03/02 from Violaine Mitchell, GAVI Financing Task Force: The Third GAVI Financing Task Force Forum was held 23-24 January 2002 at Gallaudet University, Washington D.C. One hundred people participated in the Forum, representing 50 public sector organizations and 22 countries. The Forum provided an opportunity to exchange information on FTF core priority areas of work including: immunization financing options; financial sustainability; immunization finance database; capacity building in financial management; economic and financial incentives for new vaccines; and vaccine demand forecasting and procurement. Among the highlights of the meeting ? country presentations from the governments of Bangladesh, Ghana and Pakistan on their countries? approaches to financial sustainability of immunization programs. The Forum participants supported current FTF priorities and efforts (with a number of very helpful and specific suggestions) and encouraged additional attention to: * Planning for financial sustainability of Vaccine Fund/partner investments in countries using SWAPs; * Expanding efforts to provide countries new or underused financing options for immunization such as development loans and HIPC; * Continuing improvement in vaccine demand forecasting for Fund-eligible and middle-income countries for potential future Fund; * Building national capacity in financial planning and management as part of overall capacity building strategy; * Brainstorming the feasibility/desirability of different types of public/private partnerships to accelerate the development of priority vaccines, and encourage investments such that these products are available in sufficient supply at a reasonable cost. The Forum participants identified a number of issues that go beyond the FTF? s mandate but are relevant to GAVI. These issues included recognition of the importance of dramatically increased advocacy, limitations inherent in existing health care systems, establishing effective linkages with other global initiatives, and the role of GAVI in Middle Income countries. All background information and powerpoints from the meeting are available on the website: http://www.gaviftf.org or on CD (contact: [[email protected]][email protected][/email]). NEW AND UNDERUTILIZED VACCINES 01/03/02 from Pem Namgyal, WHO/HQ: In the wake of the current shortage of combination vaccines, a document entitled "Options for introduction of hepatitis B and Haemophilus Influenzae type b vaccines into national immunization programmes" was sent to the Regional New Vaccines Officers as well as the Regional Working Group focal points in all regions. For east of reference, a copy of the document is being distributed at the same time as this information update. 01/03/02 from Gill Mayers, WHO/HQ: The Hib and HepB Management Guidelines and Fact Sheets are now available in pdf format on the following web-site: http://www.who.int/vaccines-documents/ Guidelines in Spanish and French will be available shortly. STRENGTHENING IMMUNIZATION SERVICES 01/03/02 from Jhilmil Bahl, WHO/HQ: The Third meeting of the Advisory Panel to Strengthen Immunization Services Management will be held in Geneva, Switzerland from 28 February to 1 March 2002. COUNTRY SPECIFIC INFORMATION ALBANIA 01/03/02 from Gill Mayers, WHO/HQ: HepB vaccine delivered in October 2001, and introduction scheduled for first quarter of 2002. ANGOLA 01/03/02 from Gill Mayers, WHO/HQ: Assistance has been requested with the preparation of a Vaccine Fund application for ISS for the May 2002 reviews. ARMENIA 01/03/02 from GAVI Secretariat: Application for Injection Safety has been resubmitted in 6th round. 01/03/02 from GAVI Secretariat: The GAVI Board has approved the allocation of a fixed amount of US $100,000 as an additional resource required to support the introduction of new vaccines. 01/03/02 from Gill Mayers, WHO/HQ: HepB vaccine delivered in June 2001 and introduction implemented nation-wide in October 2001. AZERBAIJAN 01/03/02 from GAVI Secretariat: The GAVI Board has approved the allocation of a fixed amount of US $100,000 as an additional resource required to support the introduction of new vaccines. 01/03/02 from Gill Mayers, WHO/HQ: HepB vaccine delivered in June 2001 and introduction implemented in October 2001. BANGLADESH 01/03/02 from GAVI Secretariat: The GAVI Board has approved the allocation of a fixed amount of US $100,000 as an additional resource required to support the introduction of new vaccines. 01/03/02 from South East Asian Regional Working Group: Immunization Advisor position has been advertised, currently awaiting selection. 01/03/02 from Gill Mayers, WHO/HQ: Release of injection safety assistance pending results of injection safety assessment to be conducted by ICDDRB in January 2002. Post for Immunization Advisor has been advertised through GoB channels, a shortlist prepared, and recruitment anticipated shortly. HepB introduction scheduled for June 2002. BENIN 01/03/02 from GAVI Secretariat: The GAVI Board has approved the allocation of a fixed amount of US $100,000 as an additional resource required to support the introduction of new vaccines. BHUTAN 01/03/02 from Gill Mayers, WHO/HQ: Comprehensive EPI review and EPI survey scheduled for December 2001 with WHO and UNICEF funding. Two consultants have been identified (Dr. Ertaza Ahmad and Dr. Naeem from Pakistan) and are expected in Bhutan by December 15 2001. GoB wants to see results of EPI review before proceeding with request for Hib burden study. BOSNIA & HERZEGOVINA 01/03/02 from Gill Mayers, WHO/HQ: A UNICEF consultant is scheduled to visit from the third week of March 2002 to assist with their Vaccine Fund application. EURO are identifying a WHO consultant to also participate in the mission. BURKINA FASO 01/03/02 from GAVI Secretariat: Applications for New Vaccines (DTP-Hib: 2003) and Injection Safety have been submitted in 6th round. BURUNDI 01/03/02 from GAVI Secretariat: The GAVI Board has approved the allocation of a fixed amount of US $100,000 as an additional resource required to support the introduction of new vaccines. CAMBODIA 01/03/02 from GAVI Secretariat: The GAVI Board has approved the allocation of a fixed amount of US $100,000 as an additional resource required to support the introduction of new vaccines. 01/03/02 from Asia Pacific Regional Working Group: * Pilot introduction of new vaccine (DTP-HepB) and AD syringes continues to progress in a few health centres of the pilot districts. * Wastage rate is currently estimated at 50%. * Plans for ISS Funds disbursement have been drafted, which include the payment of incentives for vaccinators who fully immunize a child and mother. * A meeting was held with CVP, UNICEF and WHO on 12 February 2002, with country and regional offices to delineate areas of work and improve coordination of technical support, and to plan for RWG meeting on 21-22 March 2002. 01/03/02 from Gill Mayers, WHO/HQ: DPT-HepB delivered in May 2001, and introduction started in September 2001. Dr. Osman Mansoor, WHO/WPRO to visit in 2002 to monitor progress. CAMEROON 01/03/02 from West and Central African Sub-Regional Working Group: * Measles campaign took place from 4-16 January 2002 in 43 districts in the 3 northern provinces. The estimated coverage reached during the campaign was 93%. Approximately 2,800,000 children between 9 months and 14 years were included in this campaign. Less than 10% of districts had a coverage less than 70%. * A coverage survey is being planned between 10-24 February 2002. * The second round of NIDs was officially launched by the Minister of Health and occurred between 22-26 January 2002. The main strategy used for the campaign was a door to door strategy. * Request a consultant to assist with application for New Vaccines (Yellow Fever). 01/03/02 from GAVI Secretariat: Inception report was received in February 2002. CHINA 01/03/02 from GAVI Secretariat: Application for New Vaccines (HepB) was approved in October 2001, and Memorandum of Understanding (MOU) concerning the implementation of the assistance to be provided is being drafted. COTE D?IVOIRE 01/03/02 from GAVI Secretariat: The GAVI Board has approved the allocation of a fixed amount of US $100,000 as an additional resource required to support the introduction of new vaccines. 01/03/02 from Gill Mayers, WHO/HQ: Dr. Alya Dabbagh (WHO/HQ) visited Abidjan to conduct a post-campaign AEFI follow up from 5-19 February 2002. ERITREA 01/03/02 from GAVI Secretariat: The GAVI Board has approved the allocation of a fixed amount of US $100,000 as an additional resource required to support the introduction of new vaccines. 01/03/02 from GAVI Secretariat: Application for Immunization Services Strengthening was approved after submitting clarifications. 01/03/02 from Gill Mayers, WHO/HQ: DTP-HepB delivered in December 2001 and introduced in January 2002. GAMBIA 01/03/02 from GAVI Secretariat: Conditions requested for Injection Safety application submitted in 6th round. 01/03/02 from GAVI Secretariat: Application for New Vaccines (HepB and Hib) was approved after submitting clarifications. GEORGIA 01/03/02 from GAVI Secretariat: The GAVI Board has approved the allocation of a fixed amount of US $100,000 as an additional resource required to support the introduction of new vaccines. 01/03/02 from GAVI Secretariat: Application for Injection Safety was approved after submitting clarifications. GHANA 01/03/02 from GAVI Secretariat: The GAVI Board has approved the allocation of a fixed amount of US $100,000 as an additional resource required to support the introduction of new vaccines. GUINEA 01/03/02 from GAVI Secretariat: The GAVI Board has approved the allocation of a fixed amount of US $100,000 as an additional resource required to support the introduction of new vaccines. GUINEA-BISSAU 01/03/02 from GAVI Secretariat: Applications for Immunization Services Strengthening and Injection Safety have been submitted in 6th round. GUYANA 01/03/02 from Gill Mayers, WHO/HQ: Second delivery of pentavalent vaccine received in November 2001. HAITI 01/03/02 from GAVI Secretariat: Applications for New Vaccines and Injection Safety have been submitted in 6th round. INDIA 01/03/02 from South East Asian Regional Working Group: Application for New Vaccines (HepB) has been approved. 01/03/02 from South East Asian Regional Working Group: Dr. R.K Pal has been hired as Immunization Advisor and will be in place for two years. KENYA 01/03/02 from GAVI Secretariat: The GAVI Board has approved the allocation of a fixed amount of US $100,000 as an additional resource required to support the introduction of new vaccines. 01/03/02 from GAVI Secretariat: Inception report was received in February 2002. 01/03/02 from Gill Mayers, WHO/HQ: DTP-HepB-Hib delivered in September and introduced in October/November 2001. KYRGYZSTAN 01/03/02 from Gill Mayers, WHO/HQ: Recently introduced HepB monovalent vaccine. Hib disease burden study scheduled to be carried out during 2002-2003. LAO PDR 01/03/02 from GAVI Secretariat: The GAVI Board has approved the allocation of a fixed amount of US $100,000 as an additional resource required to support the introduction of new vaccines. 01/03/02 from Asia Pacific Regional Working Group: * Pilot introduction of new vaccine (DTP-HepB) and AD syringes commenced in December 2001. Initial use has been restricted to province hospital of pilot province due to wastage concerns. * Immunization Advisor (Dr. Soulivanh) has been identified and was in place by December 2001 to provide support for new vaccine implementation and transition to AD syringes. * Further support by a consultant is expected from February to May 2002. * Costing study undertaken in February 2002 to provide key information needed for Financial Sustainability plan. Plans are still under development for use of ISS funds. 01/03/02 from Gill Mayers, WHO/HQ: DTP-HepB received in July and introduced in December 2001. LIBERIA 01/03/02 from GAVI Secretariat: The GAVI Board has approved the allocation of a fixed amount of US $100,000 as an additional resource required to support the introduction of new vaccines. MADAGASCAR 01/03/02 from GAVI Secretariat: The GAVI Board has approved the allocation of a fixed amount of US $100,000 as an additional resource required to support the introduction of new vaccines. MALAWI 01/03/02 from Gill Mayers, WHO/HQ: Dr. Rose Macauley, WHO/AFRO, attended the launch of the pentavalent which took place on 29 January 2002. Subsequent visits to provincial and district health facilities revealed that despite generally good preparedness, there were some problems with reconstitution and record-keeping ? both of which will be resolved through enhanced supervision and on-the-job training to be carried out by Supervisors over the next 2-3 months. This will be followed by a RO visit to review progress with Supervisors, consolidate information and discuss next steps. MALI 01/03/02 from GAVI Secretariat: The GAVI Board has approved the allocation of a fixed amount of US $100,000 as an additional resource required to support the introduction of new vaccines. MOLDOVA 01/03/02 from GAVI Secretariat: Application for New Vaccines (HepB) was approved after submitting clarifications. MONGOLIA 01/03/02 from Asia Pacific Regional Working Group: Immunization Advisor (Dr. Mendsaikhan) commenced in October 2001. 01/03/02 from Gill Mayers, WHO/HQ: Dr. Mary Slack, from the Haemophilus Reference Laboratory, Public Health Laboratory Service Board, John Radcliffe Hospital assisted on 28 January 2002 with training and setting up a lab to culture Hib disease. MOZAMBIQUE 01/03/02 from GAVI Secretariat: Application for Injection Safety has been submitted in 6th round. 01/03/02 from GAVI Secretariat: The GAVI Board has approved the allocation of a fixed amount of US$100,000 as an additional resource required to support the introduction of new vaccines. 01/03/02 from GAVI Secretariat: Application for New Vaccines (HepB) was approved after submitting clarifications. 01/03/02 from GAVI Secretariat: Application for New Vaccines (HepB) was approved after submitting clarifications. MYANMAR 01/03/02 from GAVI Secretariat: Conditions requested for New Vaccines (HepB) submitted in 6th round. 01/03/02 from GAVI Secretariat: Application for Immunization Services Strengthening was approved after submitting clarifications. NEPAL 01/03/02 from GAVI Secretariat: The GAVI Board has approved the allocation of a fixed amount of US$100,000 as an additional resource required to support the introduction of new vaccines. 01/03/02 from South East Asian Regional Working Group: A joint visit by the RWG, TFCC and ATF Team took place from 11-14 February 2002. The team consisted of Dr. Abdulaziz Adish (WHO/SEARO), Dr. Olivier Ronveaux (WHO/HQ), Dr. Lynda Le Le Yi (UNICEF/ROSA) and Mr. Scott Wittet (CVP/PATH). The main objective of this visit was to learn about the country?s current plans for use of ISS funds and vaccine introduction, and to offer clarification of GAVI processes and provide assistance with technical matters as needed. The team held several formal meetings with ICC members from various government agencies, WHO, UNICEF, USAID and the World Bank. The team also made presentations and participated in the discussion during the 14th meeting of the Nepali ICC meeting. 01/03/02 from South East Asian Regional Working Group: Dr. B.R. Pokharel has been hired as Immunization Advisor from January 2002. PAKISTAN 01/03/02 from GAVI Secretariat: Application for Injection Safety submitted in 6th round. 01/03/02 from GAVI Secretariat: The GAVI Board has approved the allocation of a fixed amount of US$100,000 as an additional resource required to support the introduction of new vaccines. 01/03/02 from Eastern Mediterranean Regional Working Group: One national immunization advisor has been identified, and EMRO is issuing the contract. Proposals for the second position are expected shortly. PAPUA NEW GUINEA 01/03/02 from Asia Pacific Regional Working Group: EPI review report is being finalized and will be presented to the government shortly. RWANDA 01/03/02 from GAVI Secretariat: The GAVI Board has approved the allocation of a fixed amount of US $100,000 as an additional resource required to support the introduction of new vaccines. 01/03/02 from GAVI Secretariat: Inception report was received in February 2002. 01/03/02 from Gill Mayers, WHO/HQ: Training in administering the pentavalent vaccine completed and introduction took place in January 2002. SIERRA LEONE 01/03/02 from GAVI Secretariat: Applications for New Vaccines (YF) and Injection Safety submitted in 6th round. SOMALIA 01/03/02 from Eastern Mediterranean Regional Working Group: Dr. Abdallah Bchir (Medicine Faculty of Monastir, Tunisia) and Dr. Salah Al Awaidy (National EPI Manager, Oman) visited from 29 January to 19 February 2002 to assist with preparation of documents required for the finalization of the Vaccine Fund application. The multi-year plan and injection safety action plans were also finalized during this visit. EPI review will be completed shortly. SRI LANKA 01/03/02 from Gill Mayers, WHO/HQ: A request for a Hib burden study has been received. SUDAN 01/03/02 from GAVI Secretariat: Applications for Immunization Services Strengthening and Injection Safety were approved after submitting clarifications. 01/03/02 from Eastern Mediterranean Regional Working Group: The MoH and WR have been requested to propose potential candidates for immunization advisor positions. Decisions are expected shortly. TAJIKISTAN 01/03/02 from GAVI Secretariat: The GAVI Board has approved the allocation of a fixed amount of US $100,000 as an additional resource required to support the introduction of new vaccines. 01/03/02 from GAVI Secretariat: Inception report was received in February 2002. TANZANIA 01/03/02 from GAVI Secretariat: The GAVI Board has approved the allocation of a fixed amount of US $100,000 as an additional resource required to support the introduction of new vaccines. 01/03/02 from Gill Mayers, WHO/HQ: DTP-HepB delivered in October 2001 and officially launched on 16 January 2002. Dr. Tarande Manzila, WHO/AFRO, visited from 4-8 February to assist the country to review the level of preparedness at the various district levels. Visits to health facilities revealed that in general the vaccine introduction went well. TURKMENISTAN 01/03/02 from Gill Mayers, WHO/HQ: HepB monovalent vaccine delivered end October 2001 and introduced January 2002. UKRAINE 01/03/02 from GAVI Secretariat: Conditions requested for New Vaccines (HepB) submitted in 6th round. UGANDA 01/03/02 from GAVI Secretariat: Application for Injection Safety submitted in 6th round. 01/03/02 from Rosamund Lewis, WHO/Uganda: The Training of Trainers (ToT) was held for the introduction of pentavalent vaccine from 5-9 February 2002. 01/03/02 from Gill Mayers, WHO/HQ: Pentavalent vaccine introduction scheduled for April 2002, preparatory training activities are underway. UZBEKISTAN 01/03/02 from Gill Mayers, WHO/HQ: HepB monovalent received in August 2001 and has been recently introduced. Mission on safety of injection and an inter-country workshop planned for January 2002. Hib disease burden study scheduled to be carried during 2002. YEMEN 01/03/02 from GAVI Secretariat: Application for Injection Safety submitted in 6th round. 01/03/02 from GAVI Secretariat: The GAVI Board has approved the allocation of a fixed amount of US $100,000 as an additional resource required to support the introduction of new vaccines. 01/03/02 from Eastern Mediterranean Regional Working Group: The MoH and WR have been requested to propose potential candidates for immunization advisor positions to be responsible for HepB and ISS. Decisions are expected shortly. ZAMBIA 01/03/02 from GAVI Secretariat: Application for Injection Safety submitted in 6th round. 01/03/02 from GAVI Secretariat: The GAVI Board has approved the allocation of a fixed amount of US $ 100,000 as an additional resource required to support the introduction of new vaccines. 01/03/02 from Gill Mayers, WHO/HQ: Technical assistance has been requested to conduct a HepB baseline survey. ZIMBABWE 01/03/02 from Gill Mayers, WHO/HQ: Cold chain and injection safety assessments scheduled for January 2002. REGIONAL ACTIVITIES AFRICA WEST & CENTRAL 01/03/02 from West and Central African Sub-Regional Working Group: The next West and Central African Sub-Regional Working Group meeting is scheduled for 26 February 2002 in Abidjan, Cote d?Ivoire. The objectives of the meeting are as follows: * Discuss the implementation of the outcomes presented at the previous meeting * Discuss activities from the different sub-committees * Delegate tasks to organize for the EPI Directors meeting * Discuss urgent actions required of the Sub-Regional Working Group * Exchange information on country activities 01/03/02 from West and Central African Sub-Regional Working Group: The West and Central African Sub-Regional Working Group meeting was held on 28 January 2002 in Abijdan, Cote d?Ivoire. The summary of proceedings and recommendations are as follows: Meeting for the Update on the GAVI Process: This meeting will take place from 25-26 March, and will be accommodated in the annual meeting of the EPI programme managers and partners. There is the possibility for a discussion on integrated surveillance. EPI Financial Sustainability Sub-Committee: The team was required to work on the pre-testing of the Financial Sustainability form and the comments of the RWGs and FTF and others in the Financial Sustainability guide. The RWGs have a significant role in the actual pre-test, and it should be used as a tool for the evaluation of capabilities. Working Group Sub-Committees: Five sub-committees were proposed to be established, and TORs were presented at the meeting. The group recommended that these proposals be finalized and presented at the next meeting. The five sub-committees include a) Social Mobilization; b) Financial Sustainability; c) Immunization System Strengthening; d) Capacity Building; e) Accelerated Disease Control. The sub-committees are requested to present a report on implementation of activities every two months after the development of the sub-committees. MISCELLANEOUS ? NGOs 01/03/02 from Kim Kelly, CVP/PATH: * The Children?s Vaccine Program at PATH is coordinating regional meetings for international NGOs interested in becoming more involved in immunization and learning about GAVI. * On 24 October 2001, North American-based international NGOs met in Atlanta Georgia. One of the outcomes of this meeting was identifying short and long-term activities that CVP could undertake to best represent NGOs on the GAVI Board. There was interest in forming an NGO GAVI Advisory Group. * Japanese NGO Meeting: International NGOs from Japan are invited to an informal meeting on 4 March 2002 at the International Cooperation Plaza in Tokyo, Japan. * European NGO Meeting: International European-based NGOs are invited to attend a meeting on 15 March 2002 at the CBI Conference Center in London, England. * NGO Advisory Group Meeting: Based on feedback received at the meeting in Atlanta, Georgia, CVP is exploring the possibility of organizing an NGO Advisory Group meeting during the UN Special Session on Children in New York. This would give NGOs that are deeply interested in working more closely with CVP on GAVI-related issues the opportunity to share ideas and agree on strategic direction on how best to move forward. For more information about these meetings, or the NGO Advisory Group, please contact Kim Kelly at CVP (mailto:[email protected]) ----------------------------------------------------------------------------- CONTRIBUTIONS: Contributions to: or use your reply button! The TechNet21 e-Forum welcomes new subscribers who are involved in immunization services. SUBCRIBE: To subscribe, send an e-mail to: Leave the SUBJECT area BLANK, do not type anything. In the body text, just write: Subscribe TECHNET21E Surname Name Do not use any accents in your name and surname. UNSUBSCRIBE: To unsubscribe, send an e-mail to: Leave the SUBJECT area BLANK, do not type anything. In the body text, just write: Unsubscribe TECHNET21E ------------------------------------------------------------------------------ ARCHIVES New archives of posted messages starting with 1 November 2001 is accessible to all TechNet21 subscribers. To view the archives: http://listes.ulaval.ca/listserv/archives/technet21e.html Archives for postings between 17 August 1998 and 31 October 2001 can be found at the following web site for download starting 1 December 2001. http://www.who.int/vaccines-access/Vaccines/Vaccine_Cold_Chain/Technet Archives for files (documents) are under revision to clean old documents and drafts that are already replaced with new ones, and will be made available soon at the same site. http://www.who.int/vaccines-access/Vaccines/Vaccine_Cold_Chain/Technet ----------------------------------------------------------------------------- The World Health Organization and UNICEF support TechNet21. The TechNet21 e-Forum is a communication/information tool for generation of ideas on how to improve immunization services. LISTSERV.TECHNET21.ORG
Diseases
Country


There are no replies made for this post yet.
Be one of the first to reply to this post!